Macrophage apoAI protects against dyslipidemia-induced dermatitis and atherosclerosis without affecting HDL-Reference-Cited by-同舟云学术

Macrophage apoAI protects against dyslipidemia-induced dermatitis and atherosclerosis without affecting HDL

Published:2015-03 Issue:3 Volume:56 Page:635-643
ISSN:0022-2275
Container-title:Journal of Lipid Research
language:en
Short-container-title:Journal of Lipid Research

Author:

Tavori Hagai,Su Yan Ru,Yancey Patricia G.,Giunzioni Ilaria,Wilhelm Ashley J.,Blakemore John L.,Zabalawi Manal,Linton MacRae F.,Sorci-Thomas Mary G.,Fazio Sergio

Publisher

Elsevier BV

Subject

Cell Biology,Endocrinology,Biochemistry

Reference53 articles.

1. Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study;Castelli;J. Am. Med. Assoc.,1986

2. The Munster Heart Study (PROCAM). Results of follow-up at 8 years;Assmann;Eur. Heart J.,1998

3. Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport;Rosenson;Circulation.,2012

4. Role of cholesterol and lipid organization in disease;Maxfield;Nature.,2005

5. Cardiovascular status of carriers of the apolipoprotein A-I(Milano) mutant: the Limone sul Garda study;Sirtori;Circulation.,2001

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serum ASGR2 level: an efficacy biomarker for balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension;Frontiers in Immunology;2024-05-24

2. The role of foam cells in spinal cord injury: challenges and opportunities for intervention;Frontiers in Immunology;2024-03-13

3. Lack of ApoA-I in ApoEKO Mice Causes Skin Xanthomas, Worsening of Inflammation, and Increased Coronary Atherosclerosis in the Absence of Hyperlipidemia;Arteriosclerosis, Thrombosis, and Vascular Biology;2022-07

4. Different Pathways of Cellular Cholesterol Efflux;Cell Biochemistry and Biophysics;2022-06-23

5. Cardiovascular disease in diabetes, beyond glucose;Cell Metabolism;2021-08